Aprogenex needs cash for 1995 GenSite launch:
This article was originally published in Clinica
Executive Summary
Aprogenex needs additional funding if it is to launch its maternal-blood, prenatal genetic testing system, GenSite, in Europe during the third quarter of 1995. Nevertheless, the analysis portion of the system is on target for a launch by the middle of the year.